Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts.

Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP.

J Clin Endocrinol Metab. 1995 Sep;80(9):2620-5.

PMID:
7673404
2.

Prostaglandin E2 alters human orbital fibroblast shape through a mechanism involving the generation of cyclic adenosine monophosphate.

Wang HS, Keese CR, Giaever I, Smith TJ.

J Clin Endocrinol Metab. 1995 Dec;80(12):3553-60.

PMID:
8530598
3.
4.

Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.

Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A.

J Clin Endocrinol Metab. 2002 Jan;87(1):385-92.

PMID:
11788681
5.

Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts.

Reddy L, Wang HS, Keese CR, Giaever I, Smith TJ.

Exp Cell Res. 1998 Dec 15;245(2):360-7.

PMID:
9851877
6.

Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.

Khoo TK, Coenen MJ, Schiefer AR, Kumar S, Bahn RS.

Thyroid. 2008 Dec;18(12):1291-6. doi: 10.1089/thy.2008.0255.

7.

Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts.

Cao HJ, Hogg MG, Martino LJ, Smith TJ.

Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1411-9.

PMID:
7775119
8.

Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.

Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP.

Am J Pathol. 2003 Oct;163(4):1291-300.

9.

Human orbital fibroblasts in culture express ganglioside profiles distinct from those in dermal fibroblasts.

Berenson CS, Smith TJ.

J Clin Endocrinol Metab. 1995 Sep;80(9):2668-74.

PMID:
7673410
10.

Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy.

Smith TJ, Wang HS, Hogg MG, Henrikson RC, Keese CR, Giaever I.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):5094-8.

12.

Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation.

Wang HS, Cao HJ, Winn VD, Rezanka LJ, Frobert Y, Evans CH, Sciaky D, Young DA, Smith TJ.

J Biol Chem. 1996 Sep 13;271(37):22718-28.

13.

Human thyroid fibroblasts exhibit a distinctive phenotype in culture: characteristic ganglioside profile and functional CD40 expression.

Smith TJ, Sempowski GD, Berenson CS, Cao HJ, Wang HS, Phipps RP.

Endocrinology. 1997 Dec;138(12):5576-88.

PMID:
9389546
14.

Unique properties of orbital connective tissue underlie its involvement in Graves' disease.

Smith TJ.

Minerva Endocrinol. 2003 Sep;28(3):213-22. Review.

PMID:
14605603
15.
16.

Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.

Spitzweg C, Joba W, Hunt N, Heufelder AE.

Eur J Endocrinol. 1997 Jun;136(6):599-607.

PMID:
9225723
17.

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.

Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ, Chen B, Phipps RP, Goldberg RA, Smith TJ, Douglas RS.

Invest Ophthalmol Vis Sci. 2009 May;50(5):2262-8. doi: 10.1167/iovs.08-2328. Epub 2008 Dec 30.

18.

The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy.

Mack WP, Stasior GO, Cao HJ, Stasior OG, Smith TJ.

Ophthal Plast Reconstr Surg. 1999 Jul;15(4):260-71.

PMID:
10432522
19.

Differential expression of immunoreactive HLA-DR and ICAM-1 in human cultured orbital fibroblasts and orbital tissue.

Klett ZG, Elner SG, Elner VM.

Ophthal Plast Reconstr Surg. 1996 Sep;12(3):153-62.

PMID:
8869969

Supplemental Content

Support Center